Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.
Grunwald MR, Sha W, He J, Sanikommu S, Gerber JM, Ai J, Knight TG, Fasan O, Boseman V, Kaizen W, Chojecki A, Ragon BK, Symanowski J, Avalos B, Copelan E, Ghosh N. Grunwald MR, et al. Among authors: knight tg. Transplant Cell Ther. 2024 Dec;30(12):1211.e1-1211.e11. doi: 10.1016/j.jtct.2024.09.021. Epub 2024 Sep 26. Transplant Cell Ther. 2024. PMID: 39332808
Higher Incidence of Hemorrhagic Cystitis Following Haploidentical Related Donor Transplantation Compared with Matched Related Donor Transplantation.
Copelan OR, Sanikommu SR, Trivedi JS, Butler C, Ai J, Ragon BK, Jacobs R, Knight TG, Usmani SZ, Grunwald MR, Ghosh N, Symanowski JT, Shahid Z, Clark PE, He J. Copelan OR, et al. Among authors: knight tg. Biol Blood Marrow Transplant. 2019 Apr;25(4):785-790. doi: 10.1016/j.bbmt.2018.12.142. Epub 2018 Dec 20. Biol Blood Marrow Transplant. 2019. PMID: 30579967 Free article.
Evaluation of pentamidine tolerability and efficacy between CYP2C19 phenotypes.
Koon A, He J, Patel J, Morse A, Boseman V, Hamilton A, Knight T, Shah N, Ragon B, Chojecki A, Ai J, Steuerwald N, Gerber J, Copelan E, Grunwald M, Arnall J. Koon A, et al. Pharmacogenomics. 2023 Oct;24(15):821-830. doi: 10.2217/pgs-2023-0093. Epub 2023 Oct 17. Pharmacogenomics. 2023. PMID: 37846549
Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice.
Chojecki A, Boselli D, Dortilus A, Hamadeh I, Begley S, Chen T, Bose R, Podoltsev N, Zeidan AM, Balmaceda NB, Yacoub A, Ai J, Knight TG, Ragon BK, Shah NA, Sanikommu SR, Symanowski J, Mesa R, Grunwald MR. Chojecki A, et al. Among authors: knight tg. Ann Hematol. 2024 Aug;103(8):2837-2843. doi: 10.1007/s00277-024-05735-7. Epub 2024 Apr 25. Ann Hematol. 2024. PMID: 38662203 Free PMC article.
Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF).
Chojecki AL, DiSogra KY, Arnall J, Cowgill N, Soni A, Packman CH, Sanikommu SR, Shah NA, Ragon BK, Knight TG, Ai J, Avalos BR, Copelan EA, Grunwald MR. Chojecki AL, et al. Among authors: knight tg. Leuk Lymphoma. 2022 Jun;63(6):1515-1517. doi: 10.1080/10428194.2022.2032037. Epub 2022 Feb 2. Leuk Lymphoma. 2022. PMID: 35105270 No abstract available.
Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax.
Chojecki AL, Arnall J, Boselli D, Patel R, Chiad Z, DiSogra KY, Karabinos A, Chen T, Cruz A, Verbyla A, Ai J, Knight TG, Ragon BK, Shah NA, Sanikommu SR, Symanowski J, Avalos BR, Copelan EA, Grunwald MR. Chojecki AL, et al. Among authors: knight tg. Leuk Res. 2022 Aug;119:106904. doi: 10.1016/j.leukres.2022.106904. Epub 2022 Jun 21. Leuk Res. 2022. PMID: 35753088 No abstract available.
18 results